유방의 화생성 편평상피세포암종 17예에 대한 임상 및 병리학적 분석
Metaplastic Squamous Carcinoma of the Breast: Clinicopathologic Analysis of 17 Cases
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Squamous cell carcinoma of the breast is very rare and it is considered to arise from metaplastic change of ductal carcinoma. Metaplastic squamous cell carcinoma (MSC) of the breast includes pure squamous cell carcinoma, metaplastic adenosquamous carcinoma and low grade adenosquamous carcinoma. Most of the cases of MSC of the breast were reported to have lymph node metastasis and this has a worse prognosis than that of conventional invasive ductal carcinoma. Methods : We collected 17 cases of MSC of the breast from 1,173 cases of breast cancer and analyzed the clinicopathological characteristics. Results : The age range was 31 to 69 years (mean age: 47.2). The mean tumor size was 3.6 cm. Twelve cases (70.6%) had a negative nodal status. The majority of the cases were of a high nuclear grade (grade III: 76.5%), and a high histologic grade (grade III: 88.2%). All the cases had no amplification of HER2, and they were negative for hormonal receptors, except for 2 cases with weak positivity. All the cases showed positivity for EGFR (3+: 14 cases, 1+: 3 cases). Clinical relapse was found in 3 patients on follow up and two of them expired due to lung and bone metastasis. Conclusions : MSC is associated with high nuclear and istologic grades, a high EGFR expression and they are triple negative for ER, PR, and HER2. The EGFR immunopositivity of MSC suggests a basal-like subtype.
Abstract
Background : Squamous cell carcinoma of the breast is very rare and it is considered to arise from metaplastic change of ductal carcinoma. Metaplastic squamous cell carcinoma (MSC) of the breast includes pure squamous cell carcinoma, metaplastic adenosquamous carcinoma and low grade adenosquamous carcinoma. Most of the cases of MSC of the breast were reported to have lymph node metastasis and this has a worse prognosis than that of conventional invasive ductal carcinoma. Methods : We collected 17 cases of MSC of the breast from 1,173 cases of breast cancer and analyzed the clinicopathological characteristics. Results : The age range was 31 to 69 years (mean age: 47.2). The mean tumor size was 3.6 cm. Twelve cases (70.6%) had a negative nodal status. The majority of the cases were of a high nuclear grade (grade III: 76.5%), and a high histologic grade (grade III: 88.2%). All the cases had no amplification of HER2, and they were negative for hormonal receptors, except for 2 cases with weak positivity. All the cases showed positivity for EGFR (3+: 14 cases, 1+: 3 cases). Clinical relapse was found in 3 patients on follow up and two of them expired due to lung and bone metastasis. Conclusions : MSC is associated with high nuclear and istologic grades, a high EGFR expression and they are triple negative for ER, PR, and HER2. The EGFR immunopositivity of MSC suggests a basal-like subtype.
참고문헌 (30)
- Hayes MM, "Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion", Am J Surg Pathol, 31, pp.1414~1419 (2007)
- Tavassoli FA, "Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours", pp.37~40 (2003), IARC press
- Aparicio I, "Squamous cell carcinoma of the breast", Eur J Obstet Gynecol Reprod Biol, 137, pp.222~226 (2008)
- Tot T, "Eccrine ductal and acrosyringeal differentiation of the breast epithelium: a lesion associated with some metaplastic breast carcinomas", Virchows Arch, 449, pp.565~571 (2006)
- Shigekawa T, "Squamous cell carcinoma of the breast in the form of an intracystic tumor", Breast Cancer, 14, pp.109~112 (2007)
- Rosen PP, "Low-grade adenosquamous carcinoma: a variant of metaplastic mammary carcinoma", Am J Surg Pathol, 11, pp.351~358 (1987)
- Abboud B, "Metaplastic carcinoma of the breast: case report of a sarcomatoid type and literature review", J Med Liban, 51, pp.234~237 (2003)
- Tse GM, "Metaplastic carcinoma of the breast: a clinicopathological review", J Clin Pathol, 59, pp.1079~1083 (2006)
- Luini A, "Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the EuropeanI nstitute of Oncology and review of the literature", Breast Cancer Res Treat, 101, pp.349~353 (2007)
- Sentani K, "Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma", APMIS, 115, pp.1422~1425 (2007)
- Wargotz ES, "Metaplastic carcinomas of the breast: IV. squamous cell carcinoma of ductal origin", Cancer, 65, pp.272~276 (1990)
- Kochhar R, "Metaplastic breast carcinoma with squamous differentiation: molecular and clinical analysis of six cases", Breast J, 11, pp.367~369 (2005)
- Koker MM, "P63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma", Am J Surg Pathol, 28, pp.1506~1512 (2004)
- Lee KG, "Primary squamous cell carcinoma of the breast", J Korean Cancer Assoc, 29, pp.1114~1118 (1997)
- 최승혜, "유방의 화생성 편평세포암종", 대한외과학회지, 64(2), pp.170~174 (2003), 대한외과학회
- Robbins P, "Histologic grading of breast carcinomas: a study of interobserver agreement", Hum Pathol, 26, pp.873~879 (1995)
- Allred DC, "Prognostic and predictive factors in breast cancer by immunohistochemical analysis", Mod Pathol, 11, pp.155~168 (1998)
- The Korean Breast Cancer Society, "Clinical characteristics of Korean breast cancer patients in 1998", J Korean Med Sci, 15, pp.569~579 (2000)
- Park JH, "The clinicopathologic characteristics of 38 metaplastic carcinomas of the breast", J Breast Cancer, 8, pp.59~63 (2005)
- Rayson D, "Metaplastic breast cancer: prognosis and response to systemic therapy", Ann Oncol, 10, pp.413~419 (1999)
- Huvos AG, "Metaplastic breast carcinoma:rare form of mammary carcinoma", N Y State J Med, 73, pp.1078~1082 (1973)
- Barnes P, "Metaplastic breast carcinoma:clinical-pathologic characteristics and HER2", neu expression, 2005, pp.91, 173~178
- Dent R, "Triple-negative breast cancer:clinical features and patterns of recurrence", Clin Cancer Res, 13, pp.4429~4434 (2007)
- Normanno N, "Epidermal growth factor receptor (EGFR) signaling in cancer", Gene, 366, pp.2~16 (2006)
- Hirsch FR, "Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis", J Clin Oncol, 21, pp.3798~3807 (2003)
- Kersting C, "Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of EGFR amplifications despite protein overexpression in invasive breast carcinoma", Lab Invest, 84, pp.582~587 (2004)
- Bossuyt V, "Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation", Int J Surg Pathol, 13, pp.319~327 (2005)
- Reis-Filho JS, "EGFR amplification and lack of activating mutations in metaplastic breast carcinomas", J Pathol, 209, pp.445~453 (2006)
- 김동훈, "인체 유방암종에서 p34cdc2, p27Kip1, p21WAF1", Cip1 및 p53의 발현, 2005, pp.39(6), 391~400[DOI]
- Tse GM, "P63 is useful in the diagnosis of mammary metaplastic carcinomas", Pathology, 38, pp.16~20 (2006)